10x Genomics (TXG) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

10x Genomics Revenue Highlights


Latest Revenue (Y)

$618.73M

Latest Revenue (Q)

$153.10M

Main Segment (Y)

Consumables

Main Geography (Y)

Americas

10x Genomics Revenue by Period


10x Genomics Revenue by Year

DateRevenueChange
2023-12-31$618.73M19.81%
2022-12-31$516.41M5.28%
2021-12-31$490.49M64.13%
2020-12-31$298.85M21.53%
2019-12-31$245.89M68.06%
2018-12-31$146.31M105.83%
2017-12-31$71.08M-

10x Genomics generated $618.73M in revenue during NA 2023, up 19.81% compared to the previous quarter, and up 422.88% compared to the same period a year ago.

10x Genomics Revenue by Quarter

DateRevenueChange
2024-06-30$153.10M8.58%
2024-03-31$141.01M-23.36%
2023-12-31$183.98M19.74%
2023-09-30$153.64M4.65%
2023-06-30$146.82M9.33%
2023-03-31$134.28M-14.05%
2022-12-31$156.23M19.20%
2022-09-30$131.07M14.36%
2022-06-30$114.61M0.10%
2022-03-31$114.50M-20.23%
2021-12-31$143.53M14.55%
2021-09-30$125.30M8.16%
2021-06-30$115.84M9.47%
2021-03-31$105.82M-5.70%
2020-12-31$112.22M56.26%
2020-09-30$71.82M67.39%
2020-06-30$42.91M-40.33%
2020-03-31$71.91M-4.49%
2019-12-31$75.29M23.01%
2019-09-30$61.21M9.65%
2019-06-30$55.82M4.18%
2019-03-31$53.58M5.98%
2018-12-31$50.55M38.10%
2018-09-30$36.61M15.32%
2018-06-30$31.74M7.33%
2018-03-31$29.58M-

10x Genomics generated $153.10M in revenue during Q2 2024, up 8.58% compared to the previous quarter, and up 114.01% compared to the same period a year ago.

10x Genomics Revenue Breakdown


10x Genomics Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22Dec 21Dec 20Dec 19
Service$15.70M$8.43M$7.28M$6.03M$4.07M
Consumables$479.55M$435.59M$418.74M$252.69M$206.88M
Instruments$123.47M----
Instuments-$72.40M$64.47M$40.13M$34.95M

10x Genomics's latest annual revenue breakdown by segment (product or service), as of Dec 23: Consumables (77.51%), Instruments (19.96%), and Service (2.54%).

Quarterly Revenue by Product

Product/ServiceMar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
Instruments$25.45M$38.40M$34.94M$30.95M$19.18M$20.90M$14.74M$14.43M$17.12M$16.88M$11.13M$9.68M$7.29M------
Consumables$110.33M$140.31M$114.37M$112.49M$112.38M$131.60M$108.11M$97.93M$97.95M$122.40M$106.12M$97.15M$93.08M$96.54M$60.56M$34.16M$61.43M$64.74M$49.74M
Service$5.22M$5.27M$4.33M$3.38M$2.73M$2.30M$2.07M$1.94M$2.12M$1.78M$2.06M$1.82M$1.62M$1.66M$1.58M$1.45M$1.34M$1.13M$1.08M
Instuments----------------$9.14M$9.42M$10.38M

10x Genomics's latest quarterly revenue breakdown by segment (product or service), as of Mar 24: Consumables (78.25%), Instruments (18.05%), and Service (3.70%).

10x Genomics Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 23Dec 22Dec 21Dec 20Dec 19
Asia-Pacific, Excluding China$52.29M----
Americas$373.19M----
Americas, Excluding United States$13.10M----
Asia Pacific$103.26M$46.00M$42.09M$24.51M$18.21M
UNITED STATES$360.09M$284.99M$258.27M--
EMEA$142.28M$117.07M$108.49M$73.27M$58.00M
CHINA$50.97M$59.56M$74.92M$41.74M$29.92M
North America, Excluding United States-$8.79M$6.71M--
North America---$159.33M$139.76M

10x Genomics's latest annual revenue breakdown by geography, as of Dec 23: Americas (34.08%), UNITED STATES (32.88%), EMEA (12.99%), Asia Pacific (9.43%), Asia-Pacific, Excluding China (4.77%), CHINA (4.65%), and Americas, Excluding United States (1.20%).

Quarterly Revenue by Country

CountryMar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
Asia-Pacific, Excluding China$12.73M$17.80M$10.18M$11.28M$13.04M$9.79M$9.03M$13.52M$10.19M$8.43M$11.20M--------
Asia Pacific$26.66M$29.55M$22.61M$24.03M$27.07M$7.92M$5.27M$3.30M$8.02M$3.99M$6.19M--------
Americas, Excluding United States$3.99M$4.52M$2.92M$3.15M$2.52M--------------
Americas$79.63M$103.84M$99.01M$91.54M$78.80M--------------
UNITED STATES$75.64M$99.32M$96.09M$88.39M$76.28M$82.83M$75.34M$69.37M$57.44M----------
EMEA$34.72M$50.59M$32.02M$31.25M$28.42M$43.00M$27.93M$25.61M$20.53M$34.73M$25.82M$28.77M$19.17M$32.90M$15.50M$11.71M$13.16M$21.37M$12.14M
CHINA$13.92M$11.75M$12.43M$12.76M$14.03M$13.94M$15.77M$9.09M$20.76M$19.35M$19.06M$12.87M$23.64M$14.43M$8.69M$7.63M$11.00M$7.47M$7.05M
North America, Excluding United States-----$2.79M$2.24M$1.51M$2.25M----------
North America----------$70.23M$65.77M$51.81M$56.98M$42.36M$20.26M$39.73M$42.47M$35.84M

10x Genomics's latest quarterly revenue breakdown by geography, as of Mar 24: Americas (32.20%), UNITED STATES (30.59%), EMEA (14.04%), Asia Pacific (10.78%), CHINA (5.63%), Asia-Pacific, Excluding China (5.15%), and Americas, Excluding United States (1.61%).

10x Genomics Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
TXG10x Genomics$618.73M$153.10M
GHGuardant Health$563.95M$177.24M
BEAMBeam Therapeutics$377.71M$11.77M
VCYTVeracyte$361.05M$96.84M
TWSTTwist Bioscience$245.11M$81.46M
FATEFate Therapeutics$63.53M$6.77M

TXG Revenue FAQ


10x Genomics's yearly revenue for 2023 was $618.73M, representing an increase of 19.81% compared to 2022. The company's yearly revenue for 2022 was $516.41M, representing an increase of 5.28% compared to 2021. TXG's yearly revenue for 2021 was $490.49M, representing an increase of 64.13% compared to 2020.

10x Genomics's quarterly revenue for Q2 2024 was $153.1M, a 8.58% increase from the previous quarter (Q1 2024), and a 4.28% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $141.01M, a -23.36% decrease from the previous quarter (Q4 2023), and a 5.01% increase year-over-year (Q1 2023). TXG's quarterly revenue for Q4 2023 was $183.98M, a 19.74% increase from the previous quarter (Q3 2023), and a 17.76% increase year-over-year (Q4 2022).

10x Genomics's revenue growth rate for the last 3 years (2021-2023) was 26.14%, and for the last 5 years (2019-2023) was 151.62%.

10x Genomics's revenue streams in c 23 are Service, Consumables, and Instruments. Service generated $15.7M in revenue, accounting 2.54% of the company's total revenue, up 86.39% year-over-year. Consumables generated $479.55M in revenue, accounting 77.51% of the company's total revenue, up 10.09% year-over-year. Instruments generated $123.47M in revenue, accounting 19.96% of the company's total revenue

For the fiscal year ending Dec 23, the largest source of revenue of 10x Genomics was Consumables. This segment made a revenue of $479.55M, representing 77.51% of the company's total revenue.